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The Impact of Government Health Expenditure on Health Outcomes in Southern Africa 
by Henock Shilongo 
 
Abstract  
Does government spending on health lead to better health outcomes in southern African countries? 
Government spending on health in these 10 countries (Angola, Botswana, Eswatini, Lesotho, 
Malawi Mozambique, Namibia, South Africa, Tanzania and Zambia) is greater than private sector 
health spending. A need arises to empirically estimate whether government health spending 
impacts health outcomes more than private spending. Using the fixed-effects regression method, 
this paper finds that despite more health expenditure by government, it is private health 
expenditure, in comparison, that impacts health outcomes the most in southern African countries 
with mixed health systems. The results further show that after controlling for corruption, 
government health expenditure has no significant effect on life expenditure at birth but 
considerably improves mortality rates.   
 
1. Introduction  
Statistically, OECD countries spend more on health and have better outcomes than African 
countries. The World Bank data specific to this study show that government health expenditure of 
OECD countries in 2016 was on average USD3999 per capita while for the southern African 
countries (SSA) it was only USD257 per capita (for the entire sub-Saharan Africa it was USD500 
in 2016). Total (both male and female) life expectancy at birth in OECD countries in 2016 was 
80.23 years while it was 61.61 years in southern Africa. Similarly, in both sets of countries, 
government spends more on health per capita than the private sector. The disparities that exist can 
be attributed to the difference in income levels and social economic status between the two sets of 
countries.  
 
Ideally investing in the health of a country’s population should have positive returns. Good health 
allows children to learn and adults to live long, be productive and generate income. The 
expectation is that increasing public and private health spending will increase health capital and 
consequently human capital. Table 1 presents descriptive statistics of the data used in this study. 
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The average female life expectancy (56.8) is greater than that of male citizens (52.5). The 
minimum government health spending per capita is USD1.69 while the maximum is USD600. On 
a scale of -2.5 to 2.5, corruption control in southern Africa is on average -0.24, with the lowest 
governance rating being -1.52 (Angola) while the countries with the best rating has 1.22 
(Botswana).  
 
This paper aims to determine whether a causal relationship exists between government health 
expenditure and health outcome for southern African countries and test whether the impact of 
government expenditure on health outcome is greater than private expenditure’s impact. The study 
emulates the empirical work by Arthur and Oaikhenan (2017) who conducted a similar study but 
instead covered 40 SSA countries using World Bank data from 1995 to 2014. Their main findings 
indicated that health expenditure marginally reduced mortality rates and improved life expectancy. 
Specifically, they found that public health expenditure is more significant in influencing mortality 
rates in SSA, whereas private health expenditure is significant in influencing life expectancy at 
birth. The approach taken in this paper is different from that of Arthur and Oaikhenan (2017) in 
several ways. Firstly, it focuses solely on southern African countries with governments that spend 
more on health per capita than the private sector. Secondly, it uses an updated dataset and period 
from 2000 to 2016, omitting some variables used by Arthur and Oaikhenan (2017) that were found 
to have incomplete entries for the study period. Finally, it introduces corruption control as an 
additional independent variable to capture governance performance.  
 
2. Data 
The panel data is sourced from the World Bank’s World Development Indicators and the World 
Governance Indicators for a sample of 10 southern African countries for the period 2000 to 2016. 
The dependent variables are life expectancy at birth (male and female) and mortality rates (infant 
and under 5). The main explanatory variable is government health expenditure per capita. 
Additional control variables used are described below and in more detail under the data appendix.  
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3. Empirical Model 
The Human Capital Model proposed by Grossman (1972) provides a basis to estimate the effect 
of health care spending on health outcome. This approach has been used in similar studies such as 
Fayissa and Gutema (2005) and later by Arthur and Oaikhenan (2017): 
H = F (Y, S, V, D)          (1) 
H is a vector of health outcomes (life expectancy and infant mortality), Y is a vector of economic 
variables (GDP per capita and health expenditure); S is a vector of a social and governance 
variables (education and corruption control); V is a vector of environmental factors (prevalence of 
HIV and availability of water) and D represents health service utilization proxied by measles 
immunization. Some of the variables used by Arthur and Oaikhenan (2017) were omitted from the 
regression due to missing data. For the purpose of estimation, equation 1 translates to the 
following:  
 
Ht = β0 + β1gov + β2pri + β3lnGDPpc + β4edu + β5lnmeasles + β6lnwater + β7lnHIV + β8Corr (2) + εt (2) 
 Ht is health outcomes (life expectancy and infant mortality); gov is government health expenditure 
per capita; pri is private health expenditure; lnGDPpc is the natural log of GDP per capita; edu is 
gross primary education enrollment rate; lnmeasles is the natural log of measles immunization; 
lnwater is access to clean water; lnHIV is the natural log of prevalence to HIV and Corr is control 
of corruption. 
 
Equation (2) is estimated using the fixed-effects regression method to control for omitted variables, 
(such as cultural attitudes) that vary across the southern African countries but are constant over 
time. Some limitations of the fixed-effects regression method are unobserved heterogeneity and 
the inability to control for variables that vary over time such as age or employment status of the 
people these African countries.  
 
4. Discussion of Empirical Results  
Figure 1 shows that government expenditure per capita has positive effects on life expectancy at 
birth and negative effects on infant and under-5 mortality. These results confirm a causal link 
between government health spending and health outcomes. 
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The effect of government health expenditure on health outcomes was investigated using the fixed-
effect model and the results are reported in Table 2. The coefficients of the explanatory variables 
indicate the change in health outcomes due to a one unit/percentage change in any of the 
explanatory variables, holding the other variables constant. According to the results from the 
estimation model, government health spending has no significant impact on life expectancy for 
both male and female at birth but at a 10 percent level of significance, a unit increase in government 
spending per capita reduces both infant and under-5 morality rates by 0.02 and 0.03 respectively. 
In contrast, health spending by the private sector significantly improves both male and female life 
expectancies, and greatly reduces infant and under-5 mortality rates. Health service utilization 
proxied by measles immunization in the model also proved to be very important. Specifically, a 1 
percent increase in the measles immunization rate increases life expectancy at birth of males by 
9.3 years and females by 9.4 years while reducing the rate of infant and under-5 mortality by 0.46 
and 0.54 units respectively. The study further finds meaningful estimates from environmental 
factors. The results also indicate improving to clean water significantly reduces both infant and 
under-5 mortality while the prevalence of HIV significant, at 1 percent level of significance 
reduces all the health outcomes variables. Primary school enrollment rate (social variable) plays a 
significant role in improving life expectancy at birth but does not have a significant effect on 
mortality rates. Additionally, improving governance (proxied by control of corruption) improves 
all the health outcome variables at a 1 percent level of significance.  
 
The average population of the southern African countries in this study is 1.7 billion with an average 
public spending per head of USD182. Since public health spending only has a significant causal 
effect on mortality rate, the results suggest that on average USD3.65 per capita is required to reduce 
infant mortality in southern Africa. This estimation is above the poverty line of USD1.90 a day 
which can be considered a big effect. This figure multiplied by the population suggests that 
USD6.2 billion in public funds is required to make a significant dent on the high infant mortality 
rates in the southern African region. With regards to the corruption results, the average corruption 
rate in southern Africa is -0.2 on a scale of 2.5 to -2.5. southern African countries should increase 
the corruption control on average by 0.8 to witness a huge increase in life expectancy at birth. The 
World Health Organization recommended that countries should spend 5 percent of GDP on health. 
On average southern African countries spend 3.9 percent of GDP on health which is below the 
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recommended target but with the estimated USD6.2 billion, health outcomes might improve on 
condition that corruption is also controlled.   
 
In conclusion, the results imply that private sector spending significantly impacts health outcomes 
despite higher public spending in southern Africa. Rooting out corruption can liberate more public 
funds intended to improve health outcomes and support the private sector’s impact. Empirically, 
these results somewhat agree with the findings of Gupta et al. (2002) and especially those of Arthur 
and Oaikhenan (2017). The results were adjusted for heteroscedasticity using robust standard 
errors. The coefficients of determination (R-squared) from all the estimates indicate that about 73 
percent of the variation in the health outcome variables are due to variations in the explanatory 
variables used in the study.  
 
Despite the use of panel data fixed-effect regression techniques to control for unmeasured 
heterogeneity and characteristics of countries that remain constant over time, there still exists the 
possibility of constant omitted variable bias such as cultural factors and political systems. Other 
country specific characteristics that evolve over time such as population growth, age, foreign aid, 
climate and the health system regulations might affect public and private health expenditure as 
well as the health outcome variables. In this regard, although the results in this paper are in line 
with similar studies, caution must be exercised when interpreting these results given the concerns 
raised above and the empirical approach used herein.  
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Appendix 
 
Table 1. Descriptive statistics  
Variables Mean Standard deviation Min Max 
Dependent variables      
  Life expectancy at birth, male  52.48 5.08 43.02 64.00 
  Life expectancy at birth, female 56.80 5.74 46.40 69.52 
  Infant mortality rate at birth  61.77 21.15 30.00 122.60 
  Infant mortality rate under 5 94.65 36.28 38.50 206.30 
Main independent variable      
  Government health expenditure per 
capita 
182.40 185.39 1.89 599.92 
Other variables      
  Private health expenditure per capita 116.30 126.24 2.75 475.19 
  GDP per capita 5566.78 4332.89 572.89 16175.24 
  GDP annual growth rate (%) 2.87 2.95 -9.44 11.03 
  HIV prevalence rate 14.89 7.67 1.00 28.40 
  Measles immunization rate 80.72 13.77 29.00 99.00 
  Primary school enrollment rate 106.72 13.34 67.48 142.23 
  Clean water  59.50 16.70 22.21 84.70 
  Control of corruption  -0.24 0.62 -1.52 1.22 
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Figure 1. Key Regression Results  
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Table 2. Regression results: Government health expenditure and health outcomes   
 Dependent variables  
Explanatory variables MLE FLE IMR1 IMR5 
     
Government health spending per 
capita 
0.000148 
(0.00150) 
0.000359 
(0.00154) 
-0.0201* 
(0.00801) 
-0.0257* 
(0.0106) 
 
Private health spending per capita 0.0179*** 
(0.00233) 
0.0235*** 
(0.00203) 
-0.0656** 
(0.0199) 
-0.0936** 
(0.0250) 
 
(log) GDP per capita  -1.042** 
(0.312) 
-0.486 
(0.359) 
2.168 
(1.815) 
4.905 
(2.906) 
 
Primary education enrollment 0.0386** 
(0.0105) 
0.0661*** 
(0.0114) 
-0.0865 
(0.0630) 
-0.0466 
(0.0852) 
 
 
(log) Measles immunization  9.829***  
(1.710) 
9.397*** 
(1.657) 
-45.97*** 
(7.829) 
-53.50*** 
(12.11) 
 
 
(log) Clean water   
 
-1.607 
(0.957) 
 
 
-3.487** 
(0.926) 
-19.11** 
(4.848) 
-24.65** 
(6.128) 
(log) HIV prevalence rate -6.195*** 
(0.183) 
-5.982*** 
(0.206) 
15.91*** 
(2.159) 
20.12*** 
(2.835) 
 
 
Control of corruption   
 
 
3.865*** 
(0.524) 
3.503*** 
(0.511) 
-9.209** 
(2.774) 
-21.12*** 
(4.920) 
 
 
F-value 301.9 160.3 251.2 128.9 
Prob > F 0.0000 0.0000 0.0000 0.0000 
R-squared  0.753 0.773 0.689 0.716 
Observations  140 140 140 140 
Note: All the variables in Table 2 are described in the text. The dependent variables (1) male and (2) female life 
expectancy, and (3) infant mortality at birth and (4) infant mortality under 5. All the regressions in the Table are fixed-
effect regression. The coefficients of the explanatory variables indicate the change in health outcomes due to a one 
unit/percentage change in any of the explanatory variables, holding the other variables constant. *shows significance 
at 10 percent level, ** shows significance at 5 percent level and *** shows significance at 1 percent level. Robust 
standard errors are in parentheses. 
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Data Appendix  
The following variables were used in this paper:  
Variable  World Bank Description  
Life expectancy at 
birth (male and 
female) 
Life expectancy at birth indicates the number of years a newborn infant would live if prevailing 
patterns of mortality at the time of its birth were to stay the same throughout its life. 
 
Mortality rate, 
infant (per 1,000 
live births) 
 
Infant mortality rate is the number of infants dying before reaching one year of age, per 1,000 live 
births in a given year. 
 
Mortality rate, 
under-5 (per 1,000 
live births) 
 
Under-five mortality rate is the probability per 1,000 that a newborn baby will die before reaching age 
five, if subject to age-specific mortality rates of the specified year. 
 
Domestic general 
government health 
expenditure per 
capita, PPP (current 
international $) 
 
Public expenditure on health from domestic sources per capita expressed in international dollars at 
purchasing power parity (PPP). 
 
Domestic private 
health expenditure 
per capita, PPP 
(current 
international $) 
 
Current private expenditures on health per capita expressed in international dollars at purchasing 
power parity (PPP). 
 
GDP per capita, 
PPP (constant 2011 
international $) 
 
PPP GDP is gross domestic product converted to international dollars using purchasing power parity 
rates. Data are in constant 2011 international dollars. 
 
School enrollment, 
primary (% gross) 
 
Gross enrollment ratio is the ratio of total enrollment, regardless of age, to the population of the age 
group that officially corresponds to the level of education shown. Primary education provides children 
with basic reading, writing, and mathematics skills along with an elementary understanding of such 
subjects as history, geography, natural science, social science, art, and music. 
 
Prevalence of HIV, 
total (% of 
population ages 15-
49) 
 
Prevalence of HIV refers to the percentage of people ages 15-49 who are infected with HIV. 
 
Immunization, 
measles (% of 
children ages 12-23 
months) 
 
Child immunization, measles, measures the percentage of children ages 12-23 months who received 
the measles vaccination before 12 months or at any time before the survey. A child is considered 
adequately immunized against measles after receiving one dose of vaccine. 
 
People using at least 
basic drinking water 
services (% of 
population) 
 
The percentage of people using at least basic water services.  This indicator encompasses both people 
using basic water services as well as those using safely managed water services.  Basic drinking water 
services is defined as drinking water from an improved source, provided collection time is not more 
than 30 minutes for a round trip.   
 
Control of 
Corruption 
Reflects perceptions of the extent to which public power is exercised for private gain, including both 
petty and grand forms of corruption, as well as "capture" of the state by elites and private interests. 
Estimate of governance (ranges from approximately -2.5 (weak) to 2.5 (strong) governance 
performance). 
 
